endpoint Clinical CEO Chuck Harris has decided to step down to pursue other opportunities.
Christine Oliver will succeed Harris as CEO of endpoint. Oliver joined endpoint in 2013 as an Account Director and moved to the role of VP of Operations in 2015. She was appointed to her current position as COO in 2016. Oliver brings more than 20 years’ experience in IRT and the clinical industry to her role, and has the skill and trust of the organization to continue to drive the success that endpoint has established in the marketplace.
I am very pleased that she will be taking on this role, and I have great confidence that she will lead endpoint to grow its service base to new heights and achieve continued success into the future,” Jonathan E. Shough SVP and Chief Information Officer of Covance Drug Development said.